Buy or sell Zymergen stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Zymergen Stock

Microbe Research, Development & Manufacturing



Notable Investors

Goldman Sachs


Emeryville CA, US

Total Funding


About Zymergen Stock

Zymergen researches, develops, and manufactures microbes for Fortune 500 companies. It develops molecules for agriculture, chemicals, materials, pharmaceuticals, electronics, personal care, and more applications. Zymergen’s platform integrates automation, machine learning, and genomics to navigate the genomic search space. It uses a technology platform to optimize strains in that improves economics; improves the existing production strains within existing manufacturing processes; and improves the correlation between the lab and commercial manufacturing. Moreover, Zymergen offers new product development, such as engineering any molecules from any microbes that improves the power of biology to develop novel products. Jed Dean, Joshua J. Hoffman, and Zachary Serber founded it in 2013, with its headquarters in Emeryville in California with an additional office in Seattle in Washington.


Funding History

June 2015$36.6M
June 2015$6.6M
October 2016$142M
November 2018$100.0M
November 2018$300M


Co-Founder & Chief Executive Officer

Joshua Hoffman

Co-Founder & Chief Science Officer

Zach Serber

Co-Founder & Vice President of Operatings & Engineering

Jed Dean

Chief Technical Officer

Aaron Kimball

Chief People Officer

Judy Gilbert

Chief Marketing Officer

Jack Gold


Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Zymergen or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 100K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: